WEBINAR: Navigating Orphan Medicines Regulation: Strategic Insights from the US and Europe – April 14th, 10:00 to 11:00 ET March 19, 2026

https://www.thefdalawblog.com/2026/03/webinar-navigating-orphan-medicines-regulation-strategic-insights-from-the-us-and-europe-april-14th-1000-to-1100-et/?utm_source=rss&utm_medium=rss&utm_campaign=webinar-navigating-orphan-medicines-regulation-strategic-insights-from-the-us-and-europe-april-14th-1000-to-1100-et As regulatory frameworks for orphan medicinal products continue to evolve on both sides of the Atlantic, understanding the practical and strategic implications is increasingly important. On M April 14th, 10:00 to 11:00 ET, Pinsent Masons and Hyman, Phelps & McNamara, P.C. are pleased to host a joint webinar. Catherine Drew, Partner, Pinsent Masons and Sara W. Koblitz, Director, Hyman, Phelps & McNamara will share insights into current trends and emerging issues in orphan medicines regulation and compliance. (Please note that this webinar has been rescheduled from the original date of 17 March 2026.)